Clinical Trials Browser

Phase 2 × Terminated × Biliary Tract Neoplasms × Clear all

NCT05512377 2026-05-14

Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or Bladder

Phase 2 Terminated

GastrointestinalGenitourinaryThoracic

Biliary Tract Neoplasms, Urinary Bladder Neoplasms, Lung Neoplasms, Pancreatic Neoplasms

NCT05998447 2025-12-16

GEN-001 Plus Pembrolizumab for Patients With Advanced Refractory Biliary Tract Cancer

Phase 2 Terminated

Gastrointestinal

Biliary Tract Neoplasms

NCT04779151 2025-12-01

NIRADO

Phase 2 Terminated

GastrointestinalGenitourinaryHead & Neck

Biliary Tract Neoplasms, Carcinoma, Renal Cell, Head and Neck Neoplasms

NCT04057365 2025-08-13

Study of the Combination of DKN-01 and Nivolumab in Previously Treated Patients With Advanced Biliary Tract Cancer (BTC)

Phase 2 Terminated

15 enrolled 8 charts

Gastrointestinal

Biliary Tract Neoplasms

NCT05012397 2024-10-17

Milademetan in Advanced/Metastatic Solid Tumors

Phase 2 Terminated

40 enrolled 13 charts

DermatologicEndocrineGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Testicular Germ Cell Tumor, Adenocarcinoma of Lung, Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Adrenocortical Carcinoma, Cholangiocarcinoma

NCT03291899 2024-01-17

FBI-TRAC

Phase 2 Terminated

Gastrointestinal

Biliary Tract Neoplasms

NCT04566133 2023-08-21

Combination of Trametinib (MEK Inhibitor) and Hydroxychloroquine (HCQ) (Autophagy Inhibitor) in Patients With KRAS Mutation Refractory Bile Tract Carcinoma (BTC).

Phase 2 Terminated

2 enrolled 9 charts

Gastrointestinal

Bile Duct Neoplasms, Biliary Tract Neoplasms, Cholangiocarcinoma

NCT03790111 2023-04-19

TELE-ABC

Phase 2 Terminated

53 enrolled 47 charts

Gastrointestinal

Biliary Tract Neoplasms

NCT04784520 2023-02-06

A Study of HA121-28 Tablets in Advanced Biliary Tract Cancer

Phase 2 Terminated

Gastrointestinal

Biliary Tract Neoplasms

NCT04727541 2022-05-23

NEOBIL

Phase 2 Terminated

Gastrointestinal

Biliary Tract Neoplasms, Cholangiocarcinoma

NCT01773785 2021-10-13

Phase II Study of SPI-1620 in Combination With Docetaxel as a Second-Line to Treat Biliary Cancer

Phase 2 Terminated

Gastrointestinal

Biliary Tract Neoplasms

NCT00868998 2016-05-23

GTX Regimen for Biliary Cancers

Phase 2 Terminated

4 enrolled 7 charts

Gastrointestinal

Biliary Tract Neoplasms

NCT00881504 2014-10-20

A Study of FOLFOX6 With Bevacizumab for Biliary System Carcinoma

Phase 2 Terminated

9 enrolled 7 charts

Gastrointestinal

Biliary Tract Neoplasms

NCT01171755 2014-05-21

GetBil

Phase 2 Terminated

Gastrointestinal

Biliary Tract Neoplasms

NCT01096745 2011-06-23

Randomized Trial of Gemcitabine/Cisplatin Versus S-1/Cisplatin in Advanced Biliary Cancer

Phase 2 Terminated

Gastrointestinal

Bile Duct Neoplasms, Biliary Tract Neoplasms